Earnings
RXDX
20.09
+0.65%
0.13
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
54.20M
--
--
1.09M
--
--
0.00
--
--
--
2.17M
0.00
57.46M
447.00K
--
--
--
--
--
--
1.73M
2.18M
59.63M
--
958.00K
0.00
--
--
--
--
--
5.62M
--
--
--
3.01M
15.26M
11.30M
--
--
--
4.60M
15.90M
31.15M
2000.00
1.60M
-99.15M
--
--
--
28.48M
28.48M
59.63M
FY 2019-12-31
4.45M
--
--
0.00
--
--
0.00
--
--
--
482.00K
32.60M
37.53M
321.00K
--
--
--
--
5.41M
--
7.22M
12.95M
50.48M
--
1.40M
0.00
--
--
--
--
--
2.58M
--
--
--
23.18M
31.88M
8.34M
--
--
--
3.50M
11.84M
43.71M
1000.00
482.00K
-37.45M
--
--
--
6.77M
6.77M
50.48M
FY 2018-12-31
10.88M
--
--
--
--
--
0.00
--
--
--
150.00K
--
11.03M
77.00K
--
--
--
--
--
--
--
77.00K
11.11M
--
837.00K
0.00
--
--
--
--
--
408.00K
--
--
--
--
1.25M
0.00
--
--
--
--
0.00
1.25M
1000.00
89.00K
-7.73M
--
--
--
9.86M
9.86M
11.11M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out RXDX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Prometheus Biosciences, Inc. recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.